The Ledger

Every statement that passed quotation and attribution checks. Mix any filter with any other: certainty 1/5, debate potential 5/5, or both at once.

clear all ✕

why aren't all 3 resolved? a statement only gets an assessment when the public record can support or contradict it. opinions and what-ifs never can, and 0 checkable ones are still open, waiting for their date. predictions held up or didn't; assertions are supported or contradicted. on every card: ▮▮▮▮▮ certainty · ▮▮▮▮▮ debate potential. speakers are clickable

Prediction Not checkable as stated
RFK Jr.: Medicare covering Ozempic for obesity would cost $3T yearly
“And that company is pouring tens of millions of dollars into lobbying to pass this bill that will make Medicare pay for it for every American who's obese. That could be 74% of people are now eligible. I think it's 1500 dollars a week. The cost of that will be …”
Robert F. Kennedy Jr. Aug 30, 2024 ▶ 1:50:53 In conversation with Reid Hoffman & Robert F. Kennedy Jr.
Assertion Partly supported
Ricks: Eli Lilly GLP-1 launched at 20% discount to Novo Nordisk
“We launched at a 20% discount to Nova's product, even though we have better efficacy data, and we've only cut the price since then.”
Dave Ricks Oct 8, 2024 ▶ 45:44 Dave Ricks, CEO of Eli Lilly | The All-In Interview
Assertion Supported
Ricks: Novo Nordisk's higher semaglutide dosing enabled obesity treatment
“So it was really Novo's insight that we could push up the dose of semaglutide that allowed the obesity Kind of threshold to be pushed.”
Dave Ricks Oct 8, 2024 ▶ 18:34 Dave Ricks, CEO of Eli Lilly | The All-In Interview
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 460 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.